| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |